Raffles Medical Group Ltd 2018 AR2
The report outlines Raffles Medical Group's financial and operational performance for the fiscal year 2018. The Group achieved a 2.4% growth in revenue to $489.1 million and a 3.1% increase in profit after tax to $70.8 million. Key milestones included the completion of Raffles Hospital Chongqing, Singapore's first international tertiary hospital in China, and the launch of the Raffles Shield integrated health insurance plan. The Group also advanced its digitalization journey with the rollout of the RafflesConnect e-healthcare platform. Additionally, the report highlights the Group's corporate social responsibility initiatives, such as community health screenings, medical consultations for the elderly, and clinical training partnerships.
Company: Raffles Medical Group Ltd
Sector: Healthcare & social services
Country: Singapore
Year: 2018
Type: AR2
Pages: 188
Raffles Medical Group Ltd
The report outlines Raffles Medical Group's financial and operational performance for the fiscal year 2018. The Group achieved a 2.4% growth in revenue to $489.1 million and a 3.1% increase in profit after tax to $70.8 million. Key milestones included the completion of Raffles Hospital Chongqing, Singapore's first international tertiary hospital in China, and the launch of the Raffles Shield integrated health insurance plan. The Group also advanced its digitalization journey with the rollout of the RafflesConnect e-healthcare platform. Additionally, the report highlights the Group's corporate social responsibility initiatives, such as community health screenings, medical consultations for the elderly, and clinical training partnerships.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2018
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board